Once A Cheerleader For Latest VALID Act For Diagnostics, Pew Now Has Some Reservations
Public policy group The Pew Charitable Trusts is concerned that the latest iteration of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act prioritizes a faster time to market over patient safety. The group had previously signed onto a letter praising the proposed legislation, which aims to build a new regulatory framework for diagnostics in the US.
You may also be interested in...
Senators Question User Fee Hike In Committee Hearing
The proposed MDUFA V package would almost double device user-fee funding – but is it worth it? Sen. Richard Burr, R-NC, expressed some doubts at a Tuesday committee hearing.
Abbott Preps For Potential VALID Act For Diagnostics While Pushing For More Clarity
Abbott says it’s preparing for the possible passage of legislation that would, among other things, create a new regulatory framework for diagnostic tests. But the manufacturer is also asking for more specificity around the bill’s quality requirements.
Patient Advocacy Groups Pressure US Lawmakers To Pass VALID Act For Diagnostics Regulation
The Verifying Accurate, Leading-edge IVCT Development (VALID) Act is the “most comprehensive reform effort to date” for diagnostic tests, a group of 18 patient advocacy organizations has told Congress.